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Abstract. 
 
Chemokines are a family of proinflammatory 
cytokines that attract and activate specific types of leu-
kocytes. Chemokines mediate their effects via interac-
tion with seven transmembrane G proteinÐcoupled re-
ceptors (GPCR). Using CCR5-transfected HEK-293 
cells, we show that both the CCR5 ligand, RANTES, as 
well as its derivative, aminooxypentane (AOP)-
RANTES, trigger immediate responses such as Ca
 
2
 
1
 
 
influx, receptor dimerization, tyrosine phosphorylation, 
and G
 
a
 
i
 
 as well as JAK/STAT association to the recep-
tor. In contrast to RANTES, (AOP)-RANTES is un-
able to trigger late responses, as measured by the
association of focal adhesion kinase (FAK) to the 
chemokine receptor complex, impaired cell polariza-
tion required for migration, or chemotaxis. The results 
are discussed in the context of the dissociation of the 
late signals, provoked by the chemokines required for 
cell migration, from early signals.
Key words: chemokines ¥ receptor dimerization ¥ in-
flammation ¥ HIV-1
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R
 
ANTES
 
 is a member of the continuously growing
family of chemoattractant cytokines (chemokines).
The members of this group of low molecular
weight proinflammatory cytokines are characterized by
their ability to induce migration and activation of specific
leukocyte subsets (Schall, 1994; Schall and Bacon, 1994;
Baggiolini, 1998). There are two major chemokine sub-
families, the CXC or 
 
a
 
 chemokines (in which the two cys-
teines nearest the NH
 
2
 
 terminus are separated by a single
amino acid) and the CC or 
 
b
 
 chemokines (in which these
two cysteines are adjacent). The structural similarities,
chromosomal location, and overall specificity for different
leukocyte populations concur in these families (Baggiolini
et al., 1994). Two exceptions to the CC/CXC classification
rule are as follows: lymphotactin, a chemokine lacking one
of the two conserved cysteines (Kelner et al., 1994); and
fractalkine, an integral membrane protein with a chemo-
kine domain in its NH
 
2
 
 terminus (Bazan et al., 1997).
RANTES is a CC chemokine, and interacts with several
chemokine receptors (CCR1, CCR3, CCR4, and CCR5)
(Rollins, 1997). It is a potent chemoattractant for CD4
 
1
 
and CD8
 
1
 
 lymphocytes, as well as for monocytes, NK
cells, and eosinophils (Schall et al., 1990; Taub et al., 1995;
Ugoccioni et al., 1995). RANTES can prevent infection
by macrophage-tropic HIV-1 strains (Cocchi et al., 1995;
Alkhatib et al., 1996), and its overexpression has been
demonstrated in various chronic pathologies. For example,
in experimental autoimmune encephalomyelitis, RANTES
overexpression is followed by the appearance of infiltrat-
ing cells in the central nervous system (Godiska et al.,
1995). Furthermore, in asthmalike inflammation models,
T cell and eosinophil accumulation in the lungs of sensi-
tized mice are associated with RANTES and eotaxin ex-
pression (Gonzalo et al., 1996; Jia et al., 1996). Due to the
possible relevance of this chemokine in diverse patholo-
gies, therapy based on administration of chemokine recep-
tor antagonists is a strategy for many of these diseases
(Baggiolini and Moser, 1997). Hence, RANTES deriva-
tives have been developed that lack chemotactic and
leukocyte-activating properties, and act as functional an-
tagonists (Simmons et al., 1997). This is the case for
(AOP)-RANTES, a RANTES analogue lacking the first
eight NH
 
2
 
-terminal amino acids (Arenzana-Seisdedos et
al., 1996). This analogue binds to several CC chemokine
receptors (CCR1, CCR3, CCR4, and CCR5), but does not
induce chemotaxis or enzyme release, thus acting as a 
The Journal of Cell Biology, Volume 144, 1999 756
 
RANTES antagonist (Gong et al., 1996). In addition, (AOP)-
RANTES is a potent inhibitor of macrophage-tropic HIV-1
strains that use CCR5 as a coreceptor (Arenzana-Seisde-
dos et al., 1996; Simmons et al., 1997). (AOP)-RANTES
drives the internalization of CCR5 in recombinant cell
lines and in primary cells (Mack et al., 1998).
Chemokines activate leukocytes through interaction
with single-chain seven transmembrane G proteinÐcou-
pled receptors (GPCR)
 
1
 
 (Murphy, 1994) that are grouped
in two families: CC and CXC receptors, depending on the
chemokines they bind (Murphy, 1994). To date, nine CC
and five CXC receptors have been reported, as have or-
phan receptors whose ligands remain to be elucidated. The
extracellular loops of these receptors act in concert to bind
the chemokine ligand, whereas different intracellular re-
gions are involved in transducing the chemokine signal.
Chemokine receptors are generally coupled to G
 
a
 
i
 
 pro-
teins (Bokoch, 1995), rendering cellular responses pertus-
sis toxin (PTX)-sensitive, although there are several examples
of chemokine receptors that couple to both PTX-insensi-
tive or -sensitive G proteins, as is the case of the C5a re-
ceptor (Amatruda et al., 1993). Ligand binding triggers a
number of biochemical pathways (Ward et al., 1998) that
lead to changes in intracellular cAMP levels (Ahmed et
al., 1995); phospholipase activation (Bacon et al., 1995a);
increases in tyrosine phosphorylation (Bacon et al., 1995b),
including the Src substrates focal adhesion kinase (FAK)
(p
 
125
 
 FAK) and ZAP-70 (Bacon et al., 1996); increased as-
sociation of Src family kinases with p
 
21
 
ras (Worthen et al.,
1994); and MAPK cascade activation (Jones et al., 1995;
Ganju et al., 1998).
We have recently demonstrated that the initiation of
chemokine signaling through the CCR2 chemokine recep-
tor involves ligand-triggered receptor association to mem-
bers of the Janus associated kinase (JAK) family of ty-
rosine kinases (Mellado et al., 1998), as is the case for the
cytokine receptors (OÕShea, 1997). Thus, MCP-1 associa-
tion to the CCR2 chemokine receptor induces CCR2
dimerization (Rodrguez-Frade et al., 1999) and activation
of the JAK2/STAT3 signaling pathway (Mellado et al.,
1998). RANTES and other chemokines implicated in regu-
lating T cell functions, such as MIP-1
 
a
 
, also rapidly acti-
vate some of the STAT family transcription factors (Wong
and Fish, 1998), suggesting similar dimerization-triggered
responses.
Here we analyze early RANTES and (AOP)-RANTES-
activated signaling events following binding to CCR5.
Both RANTES and its modified form, (AOP)-RANTES,
trigger tyrosine phosphorylation and activation of the
JAK1/STAT5 pathway as well as promoting dimerization
and tyrosine phosphorylation of the CCR5 receptor. While
both promote Ca
 
2
 
1
 
 influx, only RANTES induces sus-
tained cell polarization and chemotaxis, indicating the ac-
tivation of different signaling events. These data indicate
that JAK/STAT pathway activation is a general mecha-
nism for chemokine receptor activity and suggest that re-
 
ceptor dimerization and internalization may be key fea-
tures in chemokine-induced signaling.
 
Materials and Methods
 
Biological Materials
 
HEK-293 cells (ATCC TIB202) were obtained from the American Type
Culture Collection, and CCR5-transfected HEK-293 cells were kindly do-
nated by Dr. J. Gutierrez (Dept. of Immunology and Oncology, Centro
Nacional de Biotecnologa, Madrid, Spain). Antibodies used include rab-
bit anti-JAK1 and anti-JAK2 (Upstate Biotechnology, Inc.), anti-G
 
a
 
i
 
 and
anti-STAT5 (Santa Cruz Biotechnology); monoclonal anti-PTyr (4G10;
Upstate Biotechnology Inc.), anti-PTyr (PY20) (Transduction Laborato-
ries), and antiÐ
 
b
 
2
 
-microglobulin (PharMingen). Anti-CCR5 mAb, CCR5-
02, CCR5-03, and anti-CXCR4 mAb were generated in our laboratory as
described (Mellado et al., 1997). EGF-stimulated A-431 cell lysates were
obtained from Upstate Biotechnology Inc. and recombinant human
RANTES and SDF-1
 
a
 
 were from Peprotech Inc.
 
Flow Cytometry Analysis
 
Cells were centrifuged (250 
 
g
 
, 10 min, room temperature), plated in
V-bottom 96-well plates (2.5 
 
3
 
 10
 
5
 
 cells/well), and incubated with 50 
 
m
 
l/
well biotin-labeled mAb (5 
 
m
 
g/ml, 60 min, 4
 
8
 
C). Cells were washed twice
in PBS with 2% BSA and 2% FCS, and centrifuged (250 
 
g
 
, 5 min, 4
 
8
 
C).
FITC-labeled streptavidin (Southern Biotechnologies Associates, Inc.)
was added, incubated (30 min, 4
 
8
 
C) and plates were washed twice. Cell-
bound fluorescence was determined in a Profile XL flow cytometer at 525 nm
(Coulter Electronics).
 
Calcium Determination
 
Changes in intracellular calcium concentration were monitored using a
fluorescent probe (Fluo-3AM; Calbiochem). Cells (2.5 
 
3
 
 10
 
6
 
 cells/ml),
were resuspended in RPMI containing 10% FCS, 10 mM Hepes, and incu-
bated with 10 
 
m
 
l/10
 
6
 
 cells of Fluo-3AM (300 
 
m
 
M in DMSO, 15 min, 37
 
8
 
C)
(Frade et al., 1997a). After incubation, cells were washed, resuspended in
complete medium containing 2 mM CaCl
 
2
 
, and maintained at 4
 
8
 
C until
just before chemokine addition to minimize membrane trafficking and to
eliminate spontaneous Ca
 
2
 
1
 
 entry. Calcium mobilization in response to
10 nM RANTES or (AOP)-RANTES and 20 nM SDF-1
 
a
 
 was determined
at 37
 
8
 
C in an EPICS XL flow cytometer at 525 nm. It includes background
level stabilization and determination of the probe loading level for each
sample. Only samples with a similar load, as assessed by ionophore-
induced Ca
 
2
 
1
 
 mobilization, were used (5 
 
m
 
g/ml ionomycin; Sigma Chemi-
cal Co.).
 
Cell Migration
 
CCR5-transfected HEK-293 cells (0.5 
 
3
 
 10
 
6
 
 cells/ml) were starved for 120
min at 37
 
8
 
C, 5% CO
 
2
 
 in RPMI 1640 containing 0.1% BSA. Cells (0.25 
 
3
 
10
 
6
 
 cells in 0.1 ml) were placed in the upper well of 24-well, 8-
 
m
 
m pore size
transmigration chambers (Transwell; Costar Corp.) and RANTES or
(AOP)-RANTES (diluted in 0.6 ml RPMI containing 0.25% BSA) were
added to the lower well. Plates were incubated (240 min, 37
 
8
 
C, 5% CO
 
2
 
)
and the cells that migrated to the lower chamber were counted, as de-
scribed (Frade et al., 1997a).
 
Immunoprecipitation, SDS-PAGE, and Western
Blot Analysis
 
RANTES- or (AOP)-RANTESÐstimulated cells (20 
 
3
 
 10
 
6
 
) were lysed in
a detergent buffer (20 mM triethanolamine, pH 8.0, 300 mM NaCl, 2 mM
EDTA, 20% glycerol, 1% digitonin, with 10 
 
m
 
M sodium orthovanadate,
10 
 
m
 
g/ml leupeptin, and 10 
 
m
 
g/ml aprotinin) for 30 min at 4
 
8
 
C with contin-
uous rocking and then centrifuged (15,000 
 
g
 
, 15 min). Immunoprecipita-
tions were performed essentially as described earlier (Mellado et al.,
1997). Protein extracts precleared by incubation with 20 
 
m
 
g of antiÐmouse
IgM-agarose (Sigma Chemical Co.) or protein AÐSepharose (60 min, 4
 
8
 
C)
were centrifuged (15,000 
 
g
 
, 1 min), immunoprecipitated with the appropri-
ate antibody (5 
 
m
 
g/sample, 120 min, 4
 
8
 
C), followed by antiÐmouse IgM-
agarose or by protein AÐSepharose if the first antibody was derived from
rabbit serum. Immunoprecipitates or protein extracts were separated in
 
1. 
 
Abbreviations used in this paper:
 
 DSS, disuccinimidyl suberate; FAK,
focal adhesion kinase; FN, fibronectin; GPCR, G proteinÐcoupled recep-
tors; JAK, Janus associated kinase; PTX, pertussis toxin. 
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SDS-PAGE and transferred to nitrocellulose membranes. Western blot
analysis was performed as described (Mellado et al., 1997), using 2% BSA
in TBS as blocking agent for the antiphosphotyrosine analyses. When
stripping was required, membranes were incubated for 60 min at 60
 
8
 
C
with 62.5 mM Tris-HCl, pH 7.8, containing 2% SDS and 0.5% 
 
b
 
-mercap-
toethanol. After washing with 0.1% Tween 20 in TBS for 2 h, membranes
were reblocked, reprobed with the appropriate antibody, and developed
as above. In all cases, protein loading was carefully controlled using a pro-
tein detection kit (Pierce Chemical Co.) and, when necessary, by reprob-
ing the membrane with the immunoprecipitating antibody.
 
Receptor Cross-linking Assays
 
Serum starved CCR5 transfected HEK-293 cells (20 
 
3
 
 10
 
6
 
) were stimu-
lated with 10 nM RANTES, 10 nM (AOP)-RANTES, or 20 nM SDF-1
 
a
 
for 1 min at 37
 
8
 
C. The reaction was terminated by addition of 1 ml of cold
PBS and centrifugation (30 s, 15,000 
 
g
 
). After washing twice with cold
PBS, 10 
 
m
 
l of 100 mM disuccinimidyl suberate (DSS; Pierce Chemical
Co.) was added for 10 min at 4
 
8
 
C with continuous rocking. The reaction
was terminated by adding 1 ml of cold PBS and washing three times. The
pellet was lysed for 60 min and immunoprecipitated as above.
 
Immunofluorescence Microscopy: Polarization of
Blast Cells
 
Immunofluorescence experiments were performed essentially as de-
scribed (Nieto et al., 1997). Briefly, 2 
 
3
 
 10
 
6
 
 T lymphoblasts in 500 
 
m
 
l com-
plete medium were allowed to adhere to fibronectin (FN)-coated cover-
slips in 24-well plates (Costar Corp.). Cytokines and chemokines (10 ng/ml)
were added, and cells were incubated (37
 
8
 
C, 5% CO
 
2
 
). After 30 min, cells
were fixed with 3.7% formaldehyde in PBS for 10 min at room tempera-
ture, and stained with specific mAb plus a FITC-labeled rabbit antiÐ
mouse IgG F(ab
 
9
 
)
 
2
 
 (Pierce Chemical Co.). The proportion of CCR5 polar-
ization was calculated by direct cell count (
 
n
 
 
 
5
 
 400Ð500) of 10 random
fields for each condition using a photomicroscope with 60
 
3
 
 oil immersion
objectives (Labophot-2; Nikon Inc.). Preparations were photographed on
Ektachrome 400 film. Images were acquired with a high performance
CCD camera (Cohu) coupled to the microscope and connected to a work-
station (model Q550CW; Leica Imaging Systems, Ltd.). Images were visu-
alized, processed, and stored using QFISH software (version V1.01; Leica
Imaging Systems, Ltd.) and printed on a color printer (Phaser 440; Tek-
tronix Inc.).
 
Results
 
RANTES and (AOP)-RANTES Induce Functional 
Responses in CCR5-transfected HEK-293 Cells
 
We developed antiÐhuman CCR5-specific mAb using syn-
thetic peptides corresponding to the NH
 
2
 
-terminal domain
of this receptor (amino acids 13Ð28), a CCR5-specific se-
quence not present in other chemokine receptors. These
mAbs recognize the CCR5 in human PBMC (not shown)
and in CCR5 stably transfected HEK-293 cells, in flow cy-
tometry (Fig. 1 A), as well as in Western blot, and immu-
noprecipitation analysis (Fig. 1 B). No binding is observed
in mock- or CCR2-transfected HEK-293 cells, or in any
other cell tested that does not express CCR5.
In response to RANTES or (AOP)-RANTES, these
CCR5-transfected HEK-293 cells mobilize calcium (Fig. 2
A) and are desensitized to a second stimulation. However,
only RANTES triggers migration in these cells (Fig. 2 B).
PTX treatment abrogates both calcium release and cell
migration in response to RANTES and (AOP)-RANTES
(Fig. 2 A), whereas no effect was observed following incu-
bation with cholera toxin (not shown). This is consistent
with other studies showing that RANTES downstream sig-
nals in other cell lines and T cells are coupled to PTX-sen-
sitive G proteins (Bacon et al., 1995b), and with coupling
 
of other chemokine receptors to G
 
i
 
 in transfected HEK-
293 cells (Aragay et al., 1998; Mellado et al., 1998), indicat-
ing the utility of this cell line in the study of signaling
through GPCR.
We have described the ability of RANTES to polarize
peripheral blood T cells, such that the CCR5 receptor mi-
grates to the cellÕs leading edge while the ICAM-1, ICAM-3/
CD43, CD44 molecules localize at the uropod (Nieto et al.,
1997). Therefore, we tested the ability of both of these
ligands to induce polarization in peripheral T cell blasts.
Time-course studies of ICAM-3 redistribution to the cell
uropod of FN-adhered T lymphoblasts showed that RANTES
induced ICAM-3 redistribution in a significant proportion
of the cells as early as 15 min after stimulation. Maxi-
mum redistribution, seen at 30 min, persisted until at least
90 min of incubation with the chemokine. In contrast,
(AOP)-RANTESÐinduced ICAM-3 polarization showed
a much slower, weaker response, with a peak at 30 min
that vanished thereafter (Fig. 3 A).
We next studied the effects of these ligands on the po-
larization of CCR5 to the advancing front of migrating T
lymphoblasts, a phenomenon that may be involved in the
chemotaxis mechanism. We found that whereas RANTES
triggered redistribution of CCR5 molecules to the leading
edge of the cells, membrane CCR5 expression was not de-
tectable in (AOP)-RANTESÐstimulated polarized T lym-
phoblasts bearing ICAM-3 redistributed to the uropod
(Fig. 3 B). The downregulation of the (AOP)-RANTESÐ
triggered chemokine receptor results in a net inhibition of
CCR5 redistribution to the leading edge of T lymphoblasts
Figure 1. CCR5-01, -02, and -03 antibodies are specific for the
CCR5 chemokine receptor. mAb specificity for the CCR5 recep-
tor was assessed by flow cytometry analysis of mock- and CCR5-
transfected HEK-293 cells. (A) CCR5-transfected HEK-293 cells
(HEK-293-CCR5) or mock-transfected controls (HEK-293) were
incubated with the biotin-labeled CCR5-01, -02, or -03 antibod-
ies, followed by streptavidin-PE. An isotype-matched mAb was
used as a control. (B) CCR5- or mock-transfected HEK-293 cells
were immunoprecipitated as described in Materials and Methods
using CCR5-03 mAb, then analyzed in Western blot with CCR5-
01, -02, -03, or control mAb, as indicated. One representative ex-
periment of five is shown. 
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stimulated with this chemokine derivative, compared to
those treated with RANTES (Fig. 3 C). This concurs with
previous observations showing that (AOP)-RANTES in-
duces CCR5 downregulation by blocking receptor recy-
cling (Mack et al., 1998).
 
RANTES and (AOP)-RANTES Induce Tyrosine 
Phosphorylation of the CCR5 Receptor and Association 
of the JAK1/STAT5 Complex
 
When CCR5-transfected HEK-293 cells were stimulated
with RANTES or (AOP)-RANTES, a 38-kD protein
phosphorylated in tyrosine residues was initially identified
as the CCR5 receptor by immunoblot (not shown). There-
after, lysates from transfected HEK-293 cells were immu-
noprecipitated with anti-CCR5, and Western blots devel-
oped with anti-PTyr antibodies (Fig. 4). An increase in
CCR5 receptor phosphorylation in tyrosines is seen as
early as 60 s after stimulation. At this time no differences
were observed following treatment with either stimulus,
indicating that (AOP)-RANTES not only binds to CCR5,
but also signals through this receptor. The early, weak ty-
rosine phosphorylation level may occur because only one
tyrosine (Tyr 126 in the DRY motif) was being phosphory-
lated, analogous to the case of Tyr 139 in the CCR2 recep-
tor (Mellado et al., 1998). Similar results are observed in
the inverse experiment, in which anti-PTyr antibody
immunoprecipitates are analyzed in Western blot with
anti-CCR5 receptor antibody (not shown). Again, tyrosine
phosphorylation is detected in CCR5 after stimulation
with either RANTES or (AOP)-RANTES. Nevertheless,
significant differences are observed in tyrosine phosphory-
lated CCR5 after longer stimulation periods. Whereas
CCR5 phosphorylation persists in RANTES-treated cells
after 15 min of treatment, this is not the case after (AOP)-
RANTES stimulation, reinforcing the observation that
there are differences in the signaling pathways activated
by these chemokines.
To ascertain which kinase is responsible for the rapid
CCR5 chemokine receptor phosphorylation, CCR5-trans-
fected HEK-293 cells were stimulated with RANTES or
(AOP)-RANTES, and cell lysates immunoprecipitated
with anti-CCR5, or with antiÐ
 
b
 
2
 
-microglobulin as an iso-
type-matched antibody control. The use of a specific anti-
JAK1 antibody identified a 130-kD protein in the anti-
CCR5 immunoprecipitates (Fig. 5 A). Furthermore, the
JAK1 tyrosine kinase is phosphorylated on tyrosine resi-
dues after stimulation with either ligand, since anti-PTyr
immunoprecipitates can be developed with anti-JAK1 an-
tibodies in Western blot (Fig. 5 B). JAK1 association to
the CCR5 receptor takes place as early as 30 s after
RANTES or (AOP)-RANTES stimulation (Fig. 5 A).
Small amounts of JAK1 were also found associated to the
CCR5
 
 
 
receptor in the absence of added ligand, consistent
with receptor phosphorylation in the absence of exoge-
nous ligand in CCR5-transfected HEK-293 cells (Fig. 4, A
and B).
Neither immunoprecipitation of cell lysates with isotype-
matched control antibodies to other cell proteins such as
 
b
 
2
 
-microglobulin nor immunoprecipitation in mock-trans-
fected HEK-293 cells (not shown) revealed the presence
of JAK1 (Fig. 5 A). This rules out nonspecific protein as-
sociation to membrane components under these experi-
mental conditions. The rapid association of JAK1 to the
CCR5 receptor triggered by these two chemokines, but
not by others tested (MCP-1 and SDF-1
 
a
 
), suggests a role
for this tyrosine kinase in early receptor phosphorylation
following ligand stimulation. Interestingly, while MCP-1
promotes JAK2 association to the receptor in CCR2-
transfected HEK-293 cells, neither JAK2 nor JAK3 asso-
ciates to CCR5 after RANTES or (AOP)-RANTES activa-
tion of CCR5-transfected HEK-293 cells (data not shown).
To identify the downstream signaling pathway activated
by the JAK1 kinase, we tested its association to members
of the STAT transcription factor family. We analyzed
JAK1 kinase-activated STAT transcription factors in anti-
CCR5 immunoprecipitates, and found that STAT5 associ-
Figure 2. Functional responses induced by RANTES and
(AOP)-RANTES. (A) Both RANTES and (AOP)-RANTESÐ
induced Ca21 mobilization in CCR5-transfected HEK-293 cells
was desensitized by the other ligand. Pretreatment with PTX (0.1
mg/ml, 16 h) completely blocks responses in both cases. One of
three experiments is shown. Results are expressed as a percent-
age of the maximum chemokine response. (B) RANTES, but not
(AOP)-RANTES (10 nM), induces chemotaxis in CCR5-trans-
fected HEK-293 cells. PTX pretreatment (0.1 mg/ml, 16 h) blocks
the RANTES-induced response. The figure depicts one of five
experiments performed, with the SD indicated. 
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ates to the receptor complex in response to both ligands
(Fig. 5 C). The association of STAT5 correlates in time
with JAK1 phosphorylation and binding. Furthermore,
the precipitated STAT5 is phosphorylated on tyrosine res-
idues, showing it is in the activated state (Fig. 5 D). Immu-
noprecipitates of RANTES-stimulated cell lysates with
isotype-matched control antibodies do not contain STAT5.
These results were further validated by the reverse experi-
ments, in which anti-STAT5 antibodies were used for
immunoprecipitation and Western blots developed with
either anti-PTyr or anti-CCR5 antibodies (not shown).
Therefore, binding of both RANTES and (AOP)-RANTES
to the CCR5 receptor induces receptor and JAK1 phos-
phorylation and STAT5 binding. Independent of the fact
that other STAT transcriptional factors may be implicated
in CCR5-mediated signaling, our data show that no major
differences are observed in RANTES or (AOP)-RANTES
activation of the JAK/STAT pathway.
 
RANTES and (AOP)-RANTES Induce
CCR5 Dimerization
 
Similar to growth factorÐinduced dimerization of tyrosine
kinase receptors, some GPCR, including chemokine re-
ceptors like CCR2 and CXCR4, undergo ligand-induced
dimerization (Hebert et al., 1996; Rodrguez-Frade et
al., 1999; Vila-Coro, A.J., J.M. Rodrguez-Frade, A.
Martn de Ana, M.C. Moreno-Ortiz, C. Martnez-A., and
M. Mellado, manuscript submitted for publication). We
have now tested whether RANTES and (AOP)-RANTES
trigger CCR5 dimerization. DSS-mediated cross-linking in
CCR5-transfected HEK-293 cells was carried out after
RANTES or (AOP)-RANTES stimulation. In CCR5-
transfected HEK-293 cells, but not in mock-transfected
cells, a high molecular mass receptor species (76 kD) was
observed following both stimuli. This band corresponds to
the expected molecular mass of two CCR5 molecules, as
assessed by immunoprecipitation with anti-CCR5 antibod-
Figure 3. ICAM-3 and CCR5 polarization induced by RANTES and (AOP)-
RANTES in T lymphoblasts. (A) Time course of RANTES- and (AOP)-
RANTESÐinduced ICAM-3 redistribution to the uropod of T lymphoblasts. FN-
adhered (30 mg/ml) T lymphoblasts were stimulated with 10 ng/ml of RANTES or
(AOP)-RANTES for different time periods. The percentage of cells in which
ICAM-3 was redistributed was calculated as described in Materials and Methods.
One representative experiment of three is shown. (B) Membrane CCR5 expres-
sion is not detectable in (AOP)-RANTESÐstimulated polarized T lymphoblasts.
Cells adhered to FN (30 mg/ml) were stimulated with RANTES (10 ng/ml; a and
b) or (AOP)-RANTES (10 ng/ml; c and d), fixed, and stained for CCR5 (red fluo-
rescence) and ICAM-3 (green fluorescence). Cells were photographed under epi-
fluorescence (a and c) and bright-field conditions (b and d). (C) Inhibition of
CCR5 redistribution to the leading edge of (AOP)-RANTESÐpolarized T lym-
phoblasts. Cells adhered to FN (30 mg/ml) were stimulated with 10 ng/ml of
RANTES, (AOP)-RANTES, or MCP-1 for 30 min. The percentage of cells in
which CCR5 was distributed was then calculated as described in Materials and
Methods. The arithmetic mean 6 SD of three independent experiments is shown. 
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ies and Western blot developed with anti-CCR5 antibod-
ies (Fig. 6 A). When CCR5-transfected HEK-293 cells
were stimulated with SDF-1
 
a
 
, no CCR5 dimerization was
observed under these experimental conditions (Fig. 6 A),
despite the fact that HEK-293 cells express a functional
CXCR4 receptor as determined by flow cytometry and
SDF-1
 
a
 
Ðinduced calcium mobilization assays (Fig. 6 B).
When the same experiment was done using anti-CXCR4
mAb for immunoprecipitation and Western blot, a high
molecular mass species (84 kD) of the CXCR4 receptor is
observed only after SDF-1
 
a
 
, but not after RANTES or
(AOP)-RANTES stimulation (Fig. 6 B).
All together, these data indicate specific ligand-induced
dimerization, as SDF-1
 
a
 
 is not able to induce CCR5
dimerization, while RANTES or (AOP)-RANTES are not
able to induce CXCR4 dimers. In addition, association of
CCR5 with other membrane components, including other
chemokine receptors, can be discarded under these exper-
imental conditions, as cells treated with SDF-1
 
a
 
 render
only CXCR4 dimers, and those treated with RANTES and
(AOP)-RANTES render only CCR5 dimers. High molec-
ular mass species containing CCR5 and CXCR4 simulta-
neously are not detected, as shown when cells are stimu-
lated with SDF-1
 
a
 
 or RANTES and (AOP)-RANTES,
and when immunoprecipitation and Western blot are per-
formed using anti-CCR5 or anti-CXCR4 antibodies, re-
spectively. Both RANTES and (AOP)-RANTES, like
other chemokines and similar to members of the large cy-
tokine family, can trigger early signaling events such as re-
ceptor dimerization, followed by recruitment of tyrosine
kinases that phosphorylate both the receptor and the
STAT transcription factors.
 
G
 
a
 
i
 
 and p
 
125
 
FAK Association to CCR5 Differ after 
RANTES or (AOP)-RANTES Stimulation
 
The PTX dependence of RANTES- and (AOP)-
RANTESÐtriggered Ca
 
2
 
1
 
 mobilization indicates G
 
ai in-
volvement in this process. It has been demonstrated re-
cently that chemokine receptorÐmediated chemotaxis is
triggered by the bg subunit of Gai (Neptune and Bourne,
1997). In MCP-1Ðmediated chemotaxis, we have shown
that Gai associates rapidly to the CCR2 receptor, releas-
ing bg, which is responsible for activating migration and
cell polarization. Thus, we investigated whether the differ-
ences in chemotaxis triggering reflect differences in
RANTES- and (AOP)-RANTESÐmediated Gai-CCR5
receptor association.
CCR5- or mock-transfected HEK-293 cells were stimu-
lated with RANTES or (AOP)-RANTES, immunopre-
cipitated with anti-CCR5 or isotype-matched control
antibodies, followed by a Western blot with anti-Gai anti-
bodies. After both RANTES and (AOP)-RANTES stimu-
lation, Gai associated to CCR5 (Fig. 7 A). Whereas associ-
ation persisted for longer than 15 min when cells were
RANTES-stimulated, Gai is dissociated from the receptor
after 5 min of (AOP)-RANTES treatment (Fig. 7 A). The
CCR5 expression level was controlled in both immunopre-
cipitates by stripping and reblotting membranes with anti-
CCR5 antibody (Fig. 7 A). These data concur with the
similar Ca21 mobilization promoted by both of these
ligands (Fig. 2 A), as Gai association to CCR5 is unaltered
at the times employed for these experiments (1Ð3 min).
Rapid Gai dissociation from the CCR5, induced only by
(AOP)-RANTES, implies a role for Gi in later chemo-
kine-triggered events such as chemotaxis. This result con-
curs with data showing the importance of bg release from
Gi in chemotaxis (Neptune and Bourne, 1997).
The activation of p125FAK and the kinase ZAP-70 has
been described in T cells after RANTES activation (Ba-
con et al., 1996). Therefore, we tested whether p125FAK
activation coincides with its association to the CCR5.
CCR5-transfected HEK-293 cells were stimulated with
10 nM RANTES or (AOP)-RANTES, cell lysates were
immunoprecipitated with anti-p125FAK or an isotype-
matched control antibody and analyzed in Western blot
for the presence of CCR5. RANTES, but not (AOP)-
RANTES, promotes the association of this kinase to the
receptor, reaching maximum binding after 15 min (Fig. 7
B). Even in the absence of ligand, residual association
between these two proteins was observed. The lack of
p125FAK association and the rapid Gai dissociation from
the CCR5 receptor in the case of (AOP)-RANTES sug-
gest that association of these proteins with the receptor is
crucial in triggering the signaling pathways that lead to the
different effects promoted by these two chemokines.
Figure 4. Both RANTES and (AOP)-RANTES induce early
tyrosine phosphorylation of CCR5. RANTES- or (AOP)-
RANTES (10 nM)Ðinduced CCR5-transfected HEK-293 cells
were stimulated with 10 nM RANTES or (AOP)-RANTES,
lysed, immunoprecipitated with anti-CCR5 antibody, and devel-
oped in Western blot with the anti-PTyr mAb 4G10. Protein
loading was controlled using a protein detection kit (Pierce
Chemical Co.). To control for equivalent CCR5 loading, the blot
was stripped and reprobed with the anti-CCR5 mAb CCR5-02. A
control of RANTES-stimulated CCR5-transfected HEK-293 cell
lysate, immunoprecipitated with antiÐb2-microglobulin antibody,
was analyzed with anti-CCR5 antibody (not shown). One repre-
sentative experiment is shown of four performed.Rodrguez-Frade et al. Chemokine Receptor Signaling 761
Discussion
Interest is rapidly growing in a broad view of the chemo-
kine function, not only because of significance in HIV in-
fection, but also because chemokines and their receptors
are expressed by a wide variety of nonhematopoietic cells
(Horuk et al., 1997). Because of the relevance of chemo-
kines in numerous pathologies, it appears of the utmost
importance to devise therapies based on the adminis-
tration of chemokines that lack chemotactic and leuko-
cyte-activating properties, but are able to act as receptor
antagonists. These are the basic characteristics of (AOP)-
RANTES, a RANTES analogue that has been chemically
modified at its NH2 terminus, although very little is known
of the mechanism underlying its action.
We have generated anti-CCR5 mAbs and used them to
characterize the signaling pathways activated by RANTES
and (AOP)-RANTES. The results show that ligand-
induced CCR5 dimerization occurs when these chemo-
kines signal target cells for activation. In the response to
cytokines, receptor dimerization triggers a pathway in-
volving tyrosine kinases and transcriptional factors. Only
the JAK1 tyrosine kinase responds to RANTES and to
Figure 5. Both RANTES and (AOP)-RANTES activate the JAK/STAT pathway in CCR5-transfected HEK-293 cells. (A) CCR5-
transfected HEK-293 cells were stimulated with RANTES or (AOP)-RANTES (10 nM). Lysates were immunoprecipitated with mAb
CCR5-03 and analyzed in Western blot with anti-JAK1 antibodies. The figure shows control RANTES-stimulated (10 nM) CCR5-
transfected HEK-293 cell lysates immunoprecipitated with antiÐb2-microglobulin mAb and analyzed with anti-JAK1 antibodies. As a
control, CCR5-transfected HEK-293 cell lysates were tested in Western blot with the same anti-JAK1 antibodies. CCR5 protein load-
ing was controlled by stripping and reprobing membranes with mAb CCR5-02 (bottom). (B) Cells as in A were immunoprecipitated
with anti-PTyr antibody and tested in Western blot with anti-JAK1 antibodies. As a positive control, EGF-stimulated A431 cell lysates
were tested in Western blot with anti-JAK1 antibodies as above. (C) Cells as in A were immunoprecipitated with CCR5-03 mAb and
analyzed in Western blot with anti-STAT5 antibody. CCR5 protein loading was controlled as before. As a positive control, CCR5-trans-
fected HEK-293 cell lysates were tested in Western blot with the same anti-STAT5 antibody. (D) Cells as in C were immunoprecipi-
tated with anti-PTyr antibody and analyzed in Western blot with anti-STAT5 antibody. Protein loading was carefully controlled using a
protein detection kit as above. The figure shows control RANTES-stimulated (10 nM) CCR5-transfected HEK-293 cell lysates immu-
noprecipitated with antiÐMHC class I mAb and analyzed with anti-STAT5 antibodies. Arrow indicates the position of STAT5. In all
cases, one experiment of five is shown.The Journal of Cell Biology, Volume 144, 1999 762
(AOP)-RANTES by rapidly associating to CCR5 and is
phosphorylated as soon as 30 s after binding, indicating
that JAK1 activation is virtually simultaneous with its as-
sociation to CCR5. In the cytokine receptors, activation
and association of JAK kinase to the receptor creates
docking sites for SH2-containing proteins such as STAT,
leading to their phosphorylation, followed by activation of
gene transcription (Ihle, 1996). After binding of either of
the chemokine ligands studied here, STAT5 is also associ-
ated to the CCR5, in accordance with the role of the JAK
kinases in transducing signals from hematopoietic growth
factor receptors (OÕShea, 1997). Our data concur with a
recent report showing rapid activation of certain STAT
transcription factors in T cells after RANTES and MIP-1a
stimulation, although in that case association to the CCR5
receptor was not analyzed (Wong and Fish, 1998). To-
Figure 6. RANTES and (AOP)-RANTES induce dimerization
of CCR5. (A) CCR5-transfected HEK-293 cells were stimulated
for 60 s with 10 nM RANTES, 10 nM (AOP)-RANTES, or 20 nM
SDF-1a at 378C, and cross-linked using 1 mM DSS. Cell lysates
were immunoprecipitated with mAb CCR5-03, electrophoresed,
and transferred to nitrocellulose membranes. The Western blot
was analyzed with mAb CCR5-02; as a positive control, CCR5-
transfected HEK-293 cell lysates were immunoblotted with mAb
CCR5-02. Arrows indicate the CCR5 monomer (38 kD) and
dimer (76 kD). Upper corner insert shows RANTES-induced
Ca21 mobilization in CCR5-transfected HEK-293 cells, per-
formed as described in Materials and Methods. Results, ex-
pressed as in Fig. 2 A, are a percentage of the maximum chemo-
kine response. (B) CCR5-transfected HEK-293 cells as in A were
immunoprecipitated and analyzed in Western blot with anti-
CXCR4 mAb. Arrows indicate the CXCR4 monomer (42 kD)
and dimer (84 kD). Protein loading was controlled using a pro-
tein detection kit (Pierce Chemical Co.). Upper corner insert
shows SDF-1aÐinduced Ca21 mobilization in CCR5-transfected
HEK-293 cells, performed as described in Materials and Meth-
ods. Results are expressed as in A. Note that the response of
CCR5-transfected HEK-293 cells to SDF-1a is weaker than
RANTES, as measured by Ca21 influx. This lower response cor-
relates with the lower amounts of dimerized CXCR4 receptor,
and explains the longer exposure time required to develop the
Western blot for the dimerized receptor. The 52-kD protein band
corresponds to the heavy chain of the immunoprecipitating anti-
body.
Figure 7. RANTES and (AOP)-RANTES promote Gai and
p125FAK association to the CCR5 receptor. (A) 10 nM RANTES
or (AOP)-RANTESÐinduced CCR5-transfected HEK-293 cell
lysates were immunoprecipitated with anti-CCR5 (CCR5-03) or
with an antiÐb2-microglobulin control mAb, and the Western
blot developed with anti-Gai antibody. As a control for CCR5
loading equivalence, the blot was stripped and reprobed with the
anti-CCR5 mAb CCR5-02. As a positive control, CCR5-trans-
fected HEK-293 cell lysates were tested in Western blot with the
same anti-Gai or anti-CCR5 antibodies. (B) CCR5-transfected
HEK-293 cells were stimulated with RANTES or (AOP)-
RANTES as in A. Cell lysates were immunoprecipitated with
anti-p125FAK, or anti-JAK2 antibodies as control, the Western
blot developed with anti-CCR5 mAb CCR5-02. Protein loading
was controlled by stripping the membrane and reprobing with
anti-p125FAK antibody.Rodrguez-Frade et al. Chemokine Receptor Signaling 763
gether, these results indicate that chemokine-mediated ac-
tivation of GPCR leads to signal transduction, which in-
vokes intracellular phosphorylation intermediates used by
other cytokine receptors. These earlier events are equally
activated by both RANTES and (AOP)-RANTES.
Both RANTES and (AOP)-RANTES induce CCR5
dimerization, a phenomenon that requires specific interac-
tion between a given chemokine and its respective recep-
tor. When experiments were performed using SDF-1a as
a ligand neither CCR5 dimers nor CCR5-CXCR4 het-
erodimers were observed, whereas CXCR4 dimers are
present in anti-CXCR4 immunoprecipitates. Direct inter-
action between two CCR5 molecules has also been dem-
onstrated by Benkirane et al. (1997), even in the absence
of ligand stimulation. The functional significance of dimer-
ization was suggested by Hebert et al. (1996) using the
epitope tagging approach, showing that agonist stimula-
tion of the b2-adrenergic receptor stabilized the dimeric
state of the receptor. The present data indicate that al-
though dimerization is a primary event following ligand
interaction with the chemokine receptor, it does not
necessarily initiate identical transduction events. (AOP)-
RANTES thus triggers Ca21 mobilization as does RANTES,
but promotes neither cell migration nor CCR5 redistribu-
tion to the leading edge in cell polarization. The rapid Gai
association to CCR5 induced by both ligands explains the
similar Ca21 mobilization response and lack of response in
PTX-pretreated cells.
It has been shown for a number of GPCR that different
ligands of a given receptor can induce different responses.
This is the case for CXCR2, from which IL-8 and NAP-2
elicit different responses, although they bind with equiva-
lent affinity to this receptor (Ben-Baruch et al., 1997). It is
feasible that RANTES and (AOP)-RANTES induce dis-
tinct conformational changes in the CCR5. In fact, it has
been shown that different structural requirements are
needed in GPCR to activate different pathways (Hunyady
et al., 1995; Arai et al., 1997a). In the case of angiotensin II
receptor changes have been described in internalization
kinetics that do not alter other functional responses (Hun-
yady et al., 1995).
Whereas Gai association to CCR5 persists as long as 15
min after RANTES treatment, it dissociates from CCR5
by 5 min after (AOP)-RANTES stimulation. This variance
must give rise to a clear difference in the availability of
free, active bg subunits by affecting some ligand-induced
responses. In fact, Gi bg subunit release is known to be
important in chemokine receptorÐmediated chemotaxis
(Arai et al., 1997b; Neptune and Bourne, 1997). Another
conspicuous difference is the lack of late tyrosine phos-
phorylation in CCR5 after (AOP)-RANTES treatment, in
contrast to the continuous tyrosine phosphorylation of
CCR5 observed following RANTES induction. This may
occur because of tyrosine phosphorylation mediated by
other tyrosine kinases. The activation of both p125FAK
and ZAP-70 has been described after RANTES stimula-
tion (Bacon et al., 1996). Here we demonstrate association
of p125FAK, which is related to cytoskeletal proteins and
migration phenomena (Sieg et al., 1998), to the receptor
following RANTES but not (AOP)-RANTES stimulation.
The failure of (AOP)-RANTES to maintain Gi association
for long (15 min) periods concurs with the lack of associa-
tion and activation of p125FAK and the inactivation of sub-
sequent events. Both activation of Gi and p125FAK, as well
as chemotaxis, occur after RANTES activation, but are
absent when cells were treated with (AOP)-RANTES, in-
dicating a possible relationship between these events.
Chemotaxis involves several phenomena including:
changes in cell shape, integrin affinity, and integrin recy-
cling at the cellÕs leading edge (Condeelis, 1993; Lawson
and Maxfield, 1995). These events appear to be mediated
by G protein activation, as well as phosphorylation signals
through chemokine receptors (Bokoch, 1995). In fibro-
blasts and smooth muscle cells, the regulation of intracel-
lular FAK and its interaction with the cytoskeletal pro-
teins a-actinin, talin, and vinculin have also been given
much attention with respect to cell polarization and migra-
tion (Clark and Brugge, 1995; Miyamoto et al., 1995). As a
consequence of RANTES stimulation, T cells undergo a
polarization process in which the CCR5 receptor redistrib-
utes to the leading cell edge and p125FAK associates to the
receptor. Both events, implicated in the late response to
chemokines, are required for chemotaxis and are triggered
by RANTES. Early (AOP)-RANTESÐinduced signaling
events, such as Ca21 mobilization, result in weak, transient
cell polarization, and redistribution of the ICAM-3 adhe-
sion receptor to the T lymphocyte uropod. This antagonist
does not mediate cellular chemotaxis. Recycling of CCR5
molecules to the cell membrane, which probably occurs at
the advancing front of the cell and is inhibited by (AOP)-
RANTES (Mack et al., 1998), appears to be critical for the
mechanism of directional cell migration towards a chemo-
kine gradient. This is further supported by our data show-
ing the failure of CCR5 to cluster at the leading edge of
(AOP)-RANTESÐstimulated cells. Therefore, these re-
sults suggest that during the chemotaxis process early sig-
nals induced by chemokines through receptor dimeriza-
tion may not be sufficient to induce cell migration. Signals
triggered by sustained association of the G protein to the
chemokine receptor may also regulate other events neces-
sary for the chemotactic response, such as integrin affinity
or actin polymerization at the leading cell edge. Our data
also support the idea that p125FAK kinase association to
the receptor is not involved in ligand-induced CCR5
internalization, since (AOP)-RANTES is as efficient as
RANTES in promoting internalization (Mack et al., 1998),
without inducing p125FAK association.
The data presented here can be incorporated in a model
in which signaling through chemokine receptors directly
involves early signals that occur in the first few minutes af-
ter ligand binding, including receptor dimerization; associ-
ation and activation of JAK tyrosine kinases, and activa-
tion of STAT transcriptional factors, as well as late signals
such as cell polarization, activation, and association of
p125FAK kinase to the chemokine receptor (Fig. 8). The
fact that chemokine receptors activate the JAK/STAT
pathway and that dimerization may be a general mecha-
nism for chemokine activity adds a new perspective to un-
derstanding how the multiplicity of chemokine functions
are achieved. Furthermore, it suggests an interesting new
objective for therapeutic intervention in chemokine-asso-
ciated pathologies, including inflammation and AIDS.
Internalization of chemokine receptors is a phenome-
non that can be dissociated from their role as HIV-1 core-The Journal of Cell Biology, Volume 144, 1999 764
ceptors (Aramori et al., 1997; Howard et al., 1998). Al-
though the ability of the coreceptor to internalize is not
required for HIV entry, it contributes to the HIV suppres-
sive effect of CC and CXC chemokines (Amara et al.,
1997). (AOP)-RANTES is a potent inhibitor of HIV-1 in-
fectivity, an effect that is suggested because it enhanced
CCR5 internalization and inhibition of recycling (Mack
et al., 1998). As internalization is an agonist-driven event,
(AOP)-RANTES as well as other NH2-terminal modified
chemokines should be able to activate their receptors. The
differences between RANTES- and (AOP)-RANTESÐ
induced internalization may be related to increased affin-
ity of (AOP)-RANTES for the CCR5 receptor (Mack et
al., 1998), although differences in the signaling pathways
activated by these two ligands have not been reported.
Here we correlate the known effects of (AOP)-RANTES
with a signaling cascade and suggest that the dimerization
of chemokine receptors is an alternative mechanism for
chemokine-induced HIV-1 inhibition.
Receptor dimerization is also the mechanism through
which antibodies to the CCR2 NH2-terminal domain block
HIV-1 infection. In fact, the anti-CCR2 mAb CCR2-01
that blocks HIV-1 infection (Frade et al., 1997b), but not
MCP-1Ðinduced responses (Frade et al., 1997a), triggers
CCR2 dimerization (Mellado, M., manuscript in prepara-
tion). The concept that receptor dimerization is required
for prevention of HIV-1 infection, besides including the
nonsignaling mechanism indicated by (AOP)-RANTES,
incorporates the model based on receptor internalization,
which does not take place in the absence of dimerization.
For both receptor desensitization and internalization, we
have shown the requirement for GRK2 association and
phosphorylation in serine/threonine residues of the COOH-
terminal receptor domain. This in turn associates with
arrestin and clathrin, and undergoes internalization (Aragay
et al., 1998). Dimerization is a necessary event for the for-
mation of the receptor/GRK-2/arrestin/clathrin complex.
This model consolidates all available experimental evi-
dence, and offers novel prospects for screening new drugs
that may prevent HIV-1 infection and/or inflammatory
processes.
We thank Drs. R. Geha (Harvard Medical School, Boston, MA) and J.C.
Gutierrez-Ramos (Millennium Pharmaceuticals, Boston, MA) for critical
reading of the manuscript, Dr. J. Gutirrez for CCR5 transfectants, L.
Gmez for help with animals, M.C. Moreno and I. Lpez for FACS¨ anal-
ysis, and C. Bastos and C. Mark for secretarial and editorial assistance, re-
spectively.
This work was supported by grants from the Spanish Direccin Gen-
eral de Investigaciones Cientificas, European Union, the Spanish CICyT
and the Regional Government of Madrid (CAM), and Pharmacia & Upjohn.
The Department of Immunology and Oncology was founded and is sup-
ported by the Spanish Research Council (CSIC) and Pharmacia & Upjohn.
Received for publication 25 August 1998 and in revised form 18 Decem-
ber 1998.
References
Ahmed, M.U., K. Hazeki, O. Hazeki, T. Katada, and M. Ui. 1995. Cyclic AMP-
increasing agents interfere with chemoattractant-induced respiratory burst
in neutrophils as a result of the inhibition of phosphatidylinositol 3-kinase
rather than receptor-operated Ca21 influx. J. Biol. Chem. 270:23816Ð23822.
Alkhatib, G., C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Mur-
phy, and E.A. Berger. 1996. CC CKR5: A RANTES, MIP-1a, MIP-1b re-
ceptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1955Ð
1958.
Amara, A., S.L. Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetscher, M.
Baggiolini, J.L. Virelizier, and F. Arenzana-Seisdedos. 1997. HIV coreceptor
downregulation as antiviral principle: SDF-1 alpha-dependent internaliza-
tion of the chemokine receptor CXCR4 contributes to inhibition of HIV
replication. J. Exp. Med. 186:139Ð146.
Amatruda, T.T., N.P. Gerard, C. Gerard, and M.I. Simon. 1993. Specific inter-
actions of chemoattractant receptors with G proteins. J. Biol. Chem. 268:
10139Ð10144.
Aragay, A., J.M.R. Frade, M. Mellado, A. Serrano, C. Martnez-A., and F.
Mayor, Jr. 1998. MCP-1-induced CCR2B receptor desensitization by the G
protein-coupled receptor kinase-2. Proc. Natl. Acad. Sci. USA. 95:2985Ð
2990.
Arai, H., F.S. Monteclaro, C.-L. Tsou, C. Franci, and I.F. Charo. 1997a. Dissoci-
ation of chemotaxis from agonist-induced receptor internalization in a lym-
phocyte cell line transfected with CCR2B. Evidence that directed migration
does not require rapid modulation of signaling at the receptor level. J. Biol.
Chem. 272:25037Ð25042.
Arai, H., C. Tsou, and I.F. Charo. 1997b. Chemotaxis in a lymphocyte cell line
transfected with C-C-chemokine receptor 2B: evidence that direct migration
is mediated by bg dimers released by activation of Gai-coupled receptors.
Proc. Natl. Acad. Sci. USA. 94:14495Ð14499.
Aramori, Y., S.S. Ferguson, P.D. Bieniasz, J. Zhang, B. Cullen, and M.G.
Cullen. 1997. Molecular mechanism of desensitization of the chemokine re-
ceptor CCR5: receptor signaling and internalization are dissociable from its
role as an HIV-1 co-receptor. EMBO (Eur. Mol. Biol. Organ.) J. 16:4606Ð
4616.
Arenzana-Seisdedos, F., J.-L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loet-
scher, B. Moser, and M. Baggiolini. 1996. HIV blocked by chemokine antag-
onist. Nature. 383:400.
Bacon, K.B., L. Flores-Romo, P.F. Life, D.D. Taub, B.A. Premack, S.J. Arkin-
stall, T.N.C. Wells, T.J. Schall, and C.A. Power. 1995a. IL-8-induced signal
transduction in T lymphocytes involves receptor-mediated activation of
phospholipases C and D. J. Immunol. 154:3654Ð3666.
Bacon, K.B., B.A. Premack, P. Gardner, and T.J. Schall. 1995b. Activation of
dual T cell signaling pathways by the chemokine RANTES. Science. 269:
1727Ð1730.
Bacon, K.B., M.C. Szabo, H. Yssel, J.B. Bolen, and T.J. Schall. 1996. RANTES
induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in
human T cells. J. Exp. Med. 184:873Ð882.
Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565Ð568.
Baggiolini, M., and B. Moser. 1997. Blocking chemokine receptors. J. Exp.
Med. 186:1189Ð1191.
Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related
chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97Ð179.
Bazan, J.F., K.B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D.R.
Greaves, A. Zlotnik, and T.J. Schall. 1997. A new class of membrane-bound
chemokine with a CX3C motif. Nature. 385:640Ð644.
Ben-Baruch, A., M. Grimm, K. Bengali, G.A. Evans, O. Chertov, J.M. Wang,
O.M.Z. Howard, N. Mukaida, K. Matsushima, and J.J. Oppenheim. 1997.
The differential ability of IL-8 and neutrophil-activating peptide-2 to induce
attenuation of chemotaxis is mediated by their divergent capabilities to
phosphorylate CXCR2 (IL-8 receptor B). J. Immunol. 158:5927Ð5933.
Benkirane, M., D.-Y. Jin, R.F. Chun, R.A. Koup, and K.-T. Jeang. 1997. Mech-
Figure 8. Diagrammatic representation of the signals delivered
following binding of chemokines to their receptors. The emphasis
is placed on the division between early (left) and late signals
(right), indicating the biochemical signals (bottom) implicated in
the function (top). The figure shows the differential ability of
RANTES and (AOP)-RANTES to trigger early and late signals.Rodrguez-Frade et al. Chemokine Receptor Signaling 765
anism of transdominant inhibition of CCR5-mediated HIV-1 infection by
ccr5D32. J. Biol. Chem. 272:30603Ð30606.
Bokoch, G.M. 1995. Chemoattractant signaling and leukocyte activation.
Blood. 86:1649Ð1660.
Clark, E.A., and J.S. Brugge. 1995. Integrins and signal transduction pathways:
the road taken. Science. 268:233Ð239.
Cocchi, F., A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P.
Lusso. 1995. Identification of RANTES, MIP-1a, and MIP-1b as the major
HIV-suppressive factors produced by CD81 T cells. Science. 270:1811Ð1815.
Condeelis, J. 1993. Life at the leading edge: the formation of cell protrusions.
Annu. Rev. Cell. Biol. 9:411Ð444.
Frade, J.M., M. Mellado, P. Lind, J.C. Gutierrez-Ramos, and C. Martnez-A.
1997a. Characterization of the CCR2 chemokine receptor. Functional CCR2
receptor expression on B cells. J. Immunol. 159:5576Ð5584.
Frade, J.M.R., M. Llorente, M. Mellado, J. Alcam, J.C. Gutierrez-Ramos, A.
Zaballos, G. del Real, and C. Martnez-A. 1997b. The N-terminal domain of
the CCR2 chemokine receptor acts as co-receptor for HIV-1 infection. J.
Clin. Invest. 100:497Ð502.
Ganju, R.K., S.A. Brubaker, J. Meyer, P. Dutt, Y. Yang, S. Qin, W. Newman,
and J.E. Groopman. 1998. The a-chemokine, stromal cell-derived factor-1a,
binds to the transmembrane G-protein-coupled CXCR4 receptor and acti-
vates multiple signal transduction pathways. J. Biol. Chem. 273:23169Ð23175.
Godiska, R., D. Chantry, G.N. Dietsch, and T.W. Gray. 1995. Chemokine ex-
pression in murine experimental allergic encephalomyelitis. J. Neuroimmu-
nol. 58:167Ð176.
Gong, J.H., M. Uguccioni, B. Dewald, M. Baggiolini, and I. Clark-Lewis. 1996.
RANTES and MCP-3 antagonists bind multiple chemokine receptors. J.
Biol. Chem. 271:10521Ð10527.
Gonzalo, J.A., C.M. Lloyd, L. Kremer, E. Finger, C. Martnez-A., M.H. Siegel-
man, M. Cybulsky, and J.C. Gutierrez-Ramos. 1996. Eosinophil recruitment
to the lung in a murine model of allergic inflammation. The role of T cells,
chemokines, and adhesion receptors. J. Clin. Invest. 98:2332Ð2345.
Hebert, T.E., S. Moffett, J.P. Morello, T.P. Loisel, D.G. Bichet, C. Barret, and
M. Bouvier. 1996. A peptide derived from a b2-adrenergic receptor trans-
membrane domain inhibits both receptor dimerization and activation. J.
Biol. Chem. 271:16384Ð16392.
Horuk, R., A.W. Martin, Z. Wang, L. Schweitzer, A. Gerassimides, H. Guo, Z.
Lu, J. Hesselgesser, H.D. Perez, J. Kim, et al. 1997. Expression of chemokine
receptors by subsets of neurons in the central nervous system. J. Immunol.
158:2882Ð2890.
Howard, O.M., T. Korte, N.I. Tarasova, M. Grimm, J.A. Turpin, W.G. Rice,
C.J. Michejda, R. Blumenthal, and J.J. Oppenheim. 1998. Small molecule in-
hibitor of HIV-1 cell fusion blocks chemokine receptor-mediated function. J.
Leukoc. Biol. 64:6Ð13.
Hunyady, L., M. Bor, A.J. Baukal, T. Balla, and K.J. Catt. 1995. A conserved
NPLFY sequence contributes to agonist binding and signal transduction but
is not an internalization signal for the type 1 angiotensin II receptor. J. Biol.
Chem. 270:16002Ð16009.
Ihle, J.N. 1996. STATs: signal transducers and activators of transcription. Cell.
84:331Ð334.
Jia, G.-Q., J.A. Gonzalo, C. Lloyd, L. Kremer, L. Lu, C. Martnez-A., B. Wer-
shill, and J.C. Gutierrez-Ramos. 1996. Distinct expression and function of
the novel mouse chemokine mMCP-5 in lung allergic inflammation and in
lymph node germinal center. J. Exp. Med. 184:1939Ð1952.
Jones, S.A., B. Moser, and M. Thelen. 1995. A comparison of post-receptor sig-
nal transduction events in Jurkat cells transfected with either IL-8R1 or
IL-8R2 chemokine mediated activation of p42/p44 MAP-kinase (ERK-2).
FEBS (Fed. Eur. Biochem. Soc.) Lett. 364:211Ð214.
Kelner, G.S., J. Kennedy, K.B. Bacon, S. Kleyensteuber, D.A. Largaespada,
N.A. Jenkins, N.G. Copeland, J.F. Bazan, K.W. Moore, T.J. Schall, and A.
Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of
chemokine.  Science. 266:1395Ð1399.
Lawson, M.A., and F.R. Maxfield. 1995. Ca21 and calcineurin-dependent recy-
cling of an integrin to the front of migrating neutrophils. Nature. 377:75Ð79.
Mack, M., B. Lucknow, P.J. Nelson, J. Cihak, G. Simmons, P.R. Clapham, N.
Signoret, M. Marsh, M. Stangassinger, F. Borlat, et al. 1998. (AOP)-
RANTES induces CCR5 internalization but inhibits recycling: a novel inhib-
itory mechanism of HIV infectivity. J. Exp. Med. 187:1215Ð1224.
Mellado, M., J.M. Rodrguez-Frade, L. Kremer, C. von Kobbe, A. Martn de
Ana, I. Mrida, and C. Martnez-A. 1997. Conformational changes required
in the human growth hormone receptor for growth hormone signaling. J.
Biol. Chem. 272:9189Ð9196.
Mellado, M., J.M. Rodrguez-Frade, A.M. Aragay, G. del Real, A. Vila-Coro,
A. Martin de Ana, A. Serrano, F. Mayor, Jr., and C. Martnez-A. 1998. The
chemokine MCP-1 triggers JAK2 kinase activation and tyrosine phosphory-
lation of the CCR2B receptor. J. Immunol. 161:805Ð813.
Miyamoto, S., H. Teramoto, O.A. Coso, J.S. Gutkind, P.D. Durbelo, S.K. Aki-
yama, and K.M. Yamada. 1995. Integrin function: molecular hierarchies of
cytoskeletal and signaling molecules. J. Cell Biol. 131:791Ð805.
Murphy, P.M. 1994. The molecular biology of leukocyte chemoattractant recep-
tors. Annu. Rev. Immunol. 12:593Ð633.
Neptune, E.R., and H.R. Bourne. 1997. Receptors induce chemotaxis by releas-
ing the bg subunit of Gi, not by activating Gq or Gs. Proc. Natl. Acad. Sci.
USA. 94:14489Ð14494.
Nieto, M., J.M. Rodrguez-Frade, D. Sancho, M. Mellado, C. Martnez-A., and
F. Snchez-Madrid. 1997. Polarization of chemokine receptors to the leading
edge during lymphocyte chemotaxis. J. Exp. Med. 186:153Ð158.
OÕShea, J.J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregu-
lation: are we there yet? Immunity. 7:1Ð11.
Rodrguez-Frade, J.M., A.J. Vila-Coro, A. Martn De Ana, J.P. Albar, C. Mar-
tnez-A., and M. Mellado. 1999. The chemokine monocyte chemoattractant
protein-1 induces functional responses through dimerization of its receptor
CCR2. Proc. Natl. Acad. Sci. USA. In press.
Rollins, B. 1997. Chemokines. Blood. 90:909Ð928.
Schall, T.J. 1994. The chemokines. In The Cytokine Handbook. A.W. Thom-
son, editor, Academic Press, London. 181Ð272.
Schall, T.J., and K.B. Bacon. 1994. Chemokines, leukocyte trafficking, and in-
flammation. Curr. Opin. Immunol. 6:865Ð873.
Schall, T.J., K. Bacon, K.J. Toy, and D.V. Goeddel. 1990. Selective attraction of
monocytes and T lymphocytes of the memory phenotype by cytokine
RANTES.  Nature. 347:669Ð671.
Sieg, D.J., D. Llic, K.C. Jones, C.H. Damsky, T. Hunter, and D.D. Schlaepfer.
1998. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss
of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully
function to enhance FAK-cell migration. EMBO (Eur. Mol. Biol. Organ.) J.
17:5933Ð5947.
Simmons, G., P.R. Clapham, L. Picard, R.E. Offord, M.M. Rosenkilde, T.W.
Schwartz, R. Busser, T.N.C. Wells, and A.E.I. Proudfoot. 1997. Potent inhi-
bition of HIV-1 infectivity in macrophages and lymphocytes by a novel
CCR5 antagonist. Science. 276:276Ð279.
Taub, D.D., T.J. Sayers, C.R. Carter, and J.R. Ortaldo. 1995. a and b chemo-
kines induce NK cell migration and enhance NK-mediated cytolysis. J. Im-
munol. 155:3877Ð3888.
Uguccioni, M., M. DÕApuzzo, M. Loetscher, B. Dewald, and M. Baggiolini.
1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3,
RANTES, MIP-1a and MIP-1b on human monocytes. Eur. J. Immunol. 25:
64Ð68.
Ward, S.G., K. Bacon, and J. Westwick. 1998. Chemokines and T lymphocytes:
more than an attraction. Immunity. 9:1Ð11.
Wong, M., and E.N. Fish. 1998. RANTES and MIP-1a activate stats in T cells.
J. Biol. Chem. 273:309Ð314.
Worthen, G.S., N. Avdi, A.M. Buhl, N. Suzuki, and G.L. Johnson. 1994. FMLP
activates Ras and Raf in human neutrophils. Potential role in activation of
MAP kinase. J. Clin. Invest. 94:815Ð823.